Open access · OA
via OpenAlex
Type 2 diabetes – An autoinflammatory disease driven by metabolic stress
Laura L. Gonzalez, Karin Garrie, Mark D. Turner
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 2018 · ▲ 97 citations
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.bbadis.2018.08.034
- Canonical
- link ↗
- Fetched
- 2026-10-20 MST
Cite this
APA
Gonzalez, L.L., Garrie, K., & Turner, M.D. (2018). Type 2 diabetes – An autoinflammatory disease driven by metabolic stress. <em>Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease</em>. https://doi.org/10.1016/j.bbadis.2018.08.034
Vancouver
Gonzalez LL, Garrie K, Turner MD. Type 2 diabetes – An autoinflammatory disease driven by metabolic stress. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2018. doi:10.1016/j.bbadis.2018.08.034.
BibTeX
@article{laura2018Typedi,
title = {Type 2 diabetes – An autoinflammatory disease driven by metabolic stress},
author = {Laura L. Gonzalez and Karin Garrie and Mark D. Turner},
journal = {Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease},
year = {2018},
doi = {10.1016/j.bbadis.2018.08.034},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Diabetes Research and Clinical Practice 2005
Citation only
Metabolic syndrome in relationship to type 2 diabetes and atherosclerosis
Diabetes Research and Clinical Practice 2007
Preprint · CC-BY
Renal manifestations of metabolic syndrome in type 2 diabetes
Metabolism 2013
Citation only
U-shaped association of sleep duration with metabolic syndrome and insulin resistance in patients with type 2 diabetes: The Fukuoka Diabetes Registry
Diabetes Research and Clinical Practice 2003
Citation only
Components of the metabolic syndrome as predictors of cardiovascular disease and type 2 diabetes in middle-aged Japanese men
Clinica Chimica Acta 2026
Citation only
Biochemical markers of metabolic disorders: an age-specific approach to reducing type 2 diabetes and cardiovascular disease risk
Zenodo (CERN European Organization for Nuclear Research) 2025
Preprint · CC-BY